Find Academic Supervisors

Thomas DeLoughery is a Professor of Medicine, Pathology, and Pediatrics at Oregon Health & Science University (OHSU), practicing within the Divisions of Hematology/Oncology and Laboratory Medicine at the OHSU Knight Cancer Institute. His clinical expertise spans blood disorders, hemostasis, thrombosis, and hematologic aspects of wilderness and sports medicine, supported by decades of active patient care at the Center for Health & Healing and Knight Cancer Institute locations in Portland. His educational foundation includes: M.D. from Indiana University School of Medicine (1985) Internal Medicine Residency at Oregon Health & Science University (1986-1988) Hematology/Oncology Fellowship at Oregon Health & Science University (1989-1991) Dr. DeLoughery's research focuses on practical clinical challenges in hemostasis and thrombosis management, iron deficiency across diverse populations, and wilderness medicine applications. He is renowned for developing widely adopted clinical handouts (e.g., "Clotmaster consensus," "DOAC Cheat Sheet") and authoring the third edition of the handbook "Hemostasis and Thrombosis." His educational leadership includes directing OHSU's medical school Blood Course and co-developing the Blood and Host Defense curriculum. Analysis of his 2022-2024 publications reveals concentrated efforts in cancer-associated thrombosis prevention, iron deficiency management in obstetrics/gastroenterology, and wilderness medicine applications. His work consistently addresses real-world clinical dilemmas with translational impact, particularly in anticoagulation protocols and diagnostic approaches for blood disorders. He has received multiple teaching awards for his medical education contributions and maintains active professional engagement through the Wilderness Medicine Society (6-year board service, research committee chair), American College of Physicians (Master status), and Academy of Wilderness Medicine (Fellow). Dr. DeLoughery's interdisciplinary approach bridges hematology, oncology, and wilderness medicine, demonstrated through his Knight Cancer Institute affiliation and development of specialized resources for clinicians. His patient-centered philosophy is reflected in high satisfaction ratings (4.8/5 from 182 reviews) and practical clinical tools used nationally.

• Hematology
• Thrombosis
• Hemostasis
• +6 more

Aaron Saguil, MD, MPH, FAAFP serves as the Associate Dean for Recruitment and Admissions at the Uniformed Services University of the Health Sciences F. Edward Hébert School of Medicine in Bethesda, Maryland. He is also an Associate Professor of Family Medicine and faculty member at the Fort Belvoir Community Hospital Family Medicine Residency program. Dr. Saguil received his B.A. in Chemistry from Duke University and his M.D. from the University of Florida College of Medicine, followed by his Family Medicine Residency at DeWitt Army Community Hospital in Fort Belvoir, Virginia. He completed his MPH at the University of Washington and served as a Faculty Development Fellow at Madigan Army Medical Center. His research interests focus on evidence-based clinical reviews in primary care medicine, with particular expertise in diagnostic approaches to common conditions. Dr. Saguil has served in multiple military medical facilities including Grafenwoehr, Germany; Fort Lewis, Washington; and Fort Gordon, Georgia. His military service includes deployment to Afghanistan where he served as Chief of Primary Care for the NATO Role 3 Multinational Medical Unit in Kandahar. Dr. Saguil's publication record shows consistent contributions to clinical medicine, primarily through evidence-based reviews published in American Family Physician. His work spans diverse clinical topics including infectious diseases, respiratory conditions, and common primary care presentations, demonstrating his commitment to translating evidence into practical clinical guidance. Bronze Star for exceptional service in Afghanistan Canadian Chief of Defence Staff Commendation for multinational medical leadership As Vice Chair of the AAMC's MCAT Validity Committee and Chair of the AAFP's Commission on Continuing Professional Development, Dr. Saguil plays a significant role in shaping medical education standards nationally. His dual expertise in academic medicine and military healthcare administration positions him uniquely to influence both medical education and military healthcare delivery systems.

• Family Medicine
• Medical Education
• Military Medicine
• +3 more

Tony Yuan, PhD, MS, is an Assistant Professor in the Department of Radiology at the Uniformed Services University of the Health Sciences (USUHS) School of Medicine and serves as Associate Director of Research for the Center for Biotechnology (4DBio3). With over 14 years of Department of Defense (DoD) research experience, he specializes in translating biomedical innovations for military health applications including warfighter-focused diagnostics and tissue engineering solutions. Education B.A. in Biology from University of Texas at Dallas M.S. in Biotechnology from Northwestern University Ph.D. in Biomedical Engineering from University of Texas at San Antonio/UT Health San Antonio Research Interests Dr. Yuan's work spans Molecular Biology, Organ-on-a-Chip systems, Tissue Engineering, and Organoid development with emphasis on environmental sensing and diagnostic biotechnology. His research addresses critical military health challenges including wound healing, infectious disease diagnostics, and psychosocial health of service members, integrating biomaterials science with clinical applications to develop deployable solutions for battlefield medicine. Publication Trends Recent publications (2020-2022) demonstrate interdisciplinary focus on military-relevant health issues: blast-induced neurotrauma modeling using cerebral organoids, SARS-CoV-2 diagnostic systems validation, and pregnancy outcomes in military women. Earlier work (2015-2018) established foundational expertise in electrospun biomaterials for wound healing and bacterial wound pathophysiology, reflecting consistent translation of engineering principles to military medical needs across neuroscience, infectious diseases, and regenerative medicine. Scientific Awards Texas Business Hall of Fame Scholar USUHS School of Medicine Impact Award Advising and Grants Dr. Yuan has built and led multiple DoD-funded research programs including the Center for Advanced Molecular Detection (CAMD) and Joint Integrative Clinical Medicine Directorate. He secures military health research grants spanning infectious disease diagnostics, PTSD, orthopedic innovations, and maternal health, while establishing partnerships with private industry and academic institutions to accelerate technology transition for warfighter needs. Labs and Teams As Associate Director of Research for 4DBio3 at USUHS, Dr. Yuan leads biotechnology development initiatives. Previously, he directed CAMD at the 59th Medical Wing and led the Joint Integrative Clinical Medicine Directorate, managing cross-functional teams focused on unconventional exposures research, diagnostic systems, and requirement-based military medical solutions through collaborations with Naval Medical Research Units and academic partners.

• Molecular Biology
• Organ-on-a-Chip
• Tissue Engineering
• +8 more

Robert Osgood is an Associate Professor and Program Director in the Biomedical Sciences Program at Rochester Institute of Technology's College of Health Sciences and Technology. With a 23-year prior career as a medical technologist and a postdoctoral fellowship in oral microbiology at UAB, he brings extensive clinical experience to academia. His educational background includes: BS from Jackson State University MS and PhD from the University of Southern Mississippi Dr. Osgood specializes in oral microbiology and infectious disease mechanisms, with research focusing on environmental impacts (pH, oxygen) on pathogenic biofilm formation in conditions like acute otitis media. His expertise spans clinical microbiology, bacterial pathogenesis, and host-pathogen interactions, directly informing his teaching in disease-focused curricula. His scholarly work examines microbial adaptation in disease contexts, particularly how Non-typeable Haemophilus influenzae forms biofilms under varying physiological conditions—a critical factor in treatment-resistant infections. This research bridges laboratory findings with clinical applications in otolaryngology. He actively mentors students through research-intensive courses (BIOL-295/495, MEDS-290/510) and supports underrepresented scholars via LSAMP and McNair programs, which facilitate hands-on research experiences. His teaching philosophy emphasizes experiential learning in laboratory settings. Dr. Osgood directs laboratory instruction for clinical microbiology, overseeing practical training in pathogen identification and emerging infectious disease analysis through courses like MEDS-417/418, where students engage with hospital-relevant diagnostic methodologies.

• Oral Microbiology
• Microbiology
• Infectious Diseases
• +1 more

Dr. Indunil Karunarathna is a Consultant Anaesthesiologist affiliated with the Faculty of Medicine at University of Colombo, Sri Lanka, currently serving at Teaching Hospital Polonnaruwa under the Ministry of Health, Sri Lanka. He maintains additional clinical connections with Teaching Hospital Badulla and holds postdoctoral status in his field. His research interests span a remarkable breadth of medical specialties including Anaesthesiology, Critical Care, Pain Medicine, Intensive Care Medicine, Emergency Medicine, Urology, Ophthalmology, Gynecology, and Burn Surgery. His scholarly work consistently emphasizes interdisciplinary approaches to patient care, reflecting his commitment to comprehensive medical practice. Dr. Karunarathna's publication record demonstrates significant contributions across multiple medical domains, with particular focus on diagnostic precision, evidence-based therapeutic interventions, and complication prevention. His work frequently addresses the integration of advanced technologies and interprofessional collaboration in optimizing patient outcomes. Specializes in complex diagnostic challenges across multiple medical specialties Focuses on evidence-based therapeutic interventions and complication prevention Emphasizes interdisciplinary approaches to patient management Publishes on emerging diagnostic technologies and treatment paradigms His scholarly contributions reflect both clinical expertise and academic rigor, with publications addressing everything from rare genetic disorders to common clinical presentations, always with emphasis on practical clinical application and patient-centered care.

• Anaesthesiology
• Critical Care
• Pain Medicine
• +7 more

Anna Vioral, Ph.D., MEd, RN, OCN, BMTCN serves as Assistant Professor of Nursing and RN-BSN Program Coordinator at Chatham University's College of Health Sciences since 2015. With 35+ years as an oncology nurse and 20+ years in nursing education, she drives innovation in evidence-based practice and oncology nursing standards across BSN, RN-to-BSN, MSN, and DNP programs through clinical, classroom, and online instruction grounded in constructivist theory. Her educational foundation includes: BS in Nursing, Albright College MS in Nursing Education, Duquesne University Certificate in Distance Education, Penn State University Master of Adult Education, Penn State University Ph.D. in Nursing Education, Indiana University of Pennsylvania Dr. Vioral's research centers on nursing education methodology, hematology/oncology nursing practice, and evidence-based leadership. She pioneers translational approaches to chemotherapy safety standardization and develops specialized training for non-oncology nurses caring for cancer survivors, emphasizing technological integration and equitable learning environments. Her scholarship bridges clinical oncology practice with pedagogical innovation through multidisciplinary collaboration. Recent publications (2021-2023) reveal three dominant trends: pandemic-related moral injury in healthcare workers, scholarly inquiry development among nurse managers, and multidisciplinary implementation of oncology care standards. These works span nursing leadership, palliative care, and chemotherapy safety domains, consistently translating research into clinical practice improvements through evidence-based protocols. Major recognitions include: Top Ten Reviewer Recognition, Journal of Continuing Education in Nursing (2024) Pittsburgh Magazine Excellence in Nursing Awards (Researcher category, 2018 & 2022) REQ Forum Annual Recognition (2018-2024) Oncology Nursing Society Foundation Doctoral Scholarship (2009) Multiple Indiana University Pennsylvania Doctoral Fellowships (2012-2013) As Principal Investigator or co-PI, she has secured significant research funding including a $30,000 Susan G. Komen Foundation grant through ONS and Allegheny Health Network support for oncology patient experience initiatives. Current projects address moral distress during pandemics and mobile-based oncology competency development. She actively mentors nursing students through the RN-BSN program while maintaining clinical certifications (OCN, BMTCN). Dr. Vioral contributes to oncology advancement through leadership roles in AACN, ASCO, ONS, and the Leukemia and Lymphoma Society, driving national standards for chemotherapy safety and cancer survivorship care.

• Nursing Education
• Nursing Research and Evidence-Based Practice
• Nursing Leadership
• +1 more

Marcie L. Billings, M.D. is a Clinical Professor at Mayo Clinic College of Medicine, serving as a Consultant in the Division of Community Pediatric and Adolescent Medicine within the Department of Pediatric and Adolescent Medicine at Mayo Clinic in Rochester, Minnesota. With over two decades of experience since completing her medical training, Dr. Billings has established herself as a leader in adolescent medicine, particularly in the areas of eating disorders and their integration into primary care settings. Dr. Billings' research focuses on adolescent medicine with special emphasis on eating disorders, adolescent gynecology, and child abuse. Her groundbreaking work has centered on adapting family-based treatment approaches for eating disorders within primary care settings, addressing critical healthcare disparities, and developing collaborative care models for adolescent mental health. She has demonstrated how primary care providers can effectively manage eating disorders, bridging the significant gap for adolescents who face barriers to specialized treatment. 2014 Karis Award Mayo Clinic Values Council 2010 Excellence Through Teamwork Award Employee Recognition Program, Department of Human Resources 2008 Excellence Through Teamwork Award Employee Recognition Program, Department of Human Resources Dr. Billings has held numerous leadership positions including Associate Program Director of the Pediatric Residency Program (2001-2008), Chair of the Social Committee, and various committee roles such as Chair of the ECH Practice High Value Care Committee (2012-2019) and Chair of the Dermatology Task Force (2009-2014). Her professional memberships include the American Medical Association (2009-present) and the American Academy of Pediatrics (2001-present). As evidenced by her extensive publication record from 2011 to 2025, Dr. Billings has made significant contributions to integrating specialized adolescent mental health treatments into primary care settings. Her work addresses practical implementation challenges, healthcare disparities, and training needs for primary care providers managing complex adolescent conditions, particularly eating disorders.

• Adolescent medicine
• Adolescent gynecology
• Child abuse
• +5 more

Dr. Leslie J. Padrnos is an Assistant Professor of Medicine at Mayo Clinic College of Medicine in Phoenix, Arizona, specializing in Hematology and Medical Oncology with particular expertise in nonmalignant hematology. She serves in multiple leadership roles including Chair of the Mayo Arizona Multidisciplinary Bleeding Meeting, Chair of the Non-Malignant Hematology Conference, and Chair of the Coagulation and Thrombosis Board. As Core Faculty for the Hematology Oncology Fellowship program, she plays a significant role in medical education and resident supervision. Dr. Padrnos's research focuses on thrombosis and hemostasis conditions, with particular emphasis on complex thrombotic disorders, cancer-associated thrombosis, and bleeding disorders. Her clinical work integrates comprehensive medical knowledge with psychological management and patient education to optimize individual patient outcomes. She has published extensively on topics including anticoagulation therapy, venous thromboembolism, and hematologic complications of cancer and other conditions. Her recent publications demonstrate significant contributions to the understanding of thrombosis in the context of emerging health challenges including the COVID-19 pandemic, with research on vaccine-related thrombotic events and optimal anticoagulation strategies. Her work spans both clinical research and educational interventions aimed at improving patient outcomes and knowledge. 2024 ASH Ambassador Faculty with Student Interest Group Subcommittee, American Society of Hematology 2023 Medical Educators Institute, American Society of Hematology 2020 Hematology Oncology & Palliative Medicine Teacher of the Year Award 2017 Mayo Clinic Scholar, Seattle Cancer Care Alliance 2016 Clinical Research Training Institute, American Society of Hematology 2016 Chief Hematology Oncology Fellow Dr. Padrnos supervises Internal Medicine residents during their hematology rotations and mentors hematology/oncology fellows through her Core Faculty role. She has developed meaningful clinical programs focused on bleeding disorders and thrombosis management, with particular attention to patient-centered care approaches that incorporate individual goals and values. Her leadership extends to multiple committees including the Pharmacy and Therapeutic Subcommittee and the Scientific and Standardization Committee on Hemostasis and Malignancy with the International Society of Thrombosis and Hemostasis. She leads the Non-Malignant Hematology and Thrombosis Research Group at Mayo Clinic Arizona, focusing on clinical research that bridges the gap between laboratory findings and patient care. Her team investigates optimal management strategies for complex thrombotic conditions and bleeding disorders, with particular attention to cancer-associated thrombosis and anticoagulation selection.

• Hematology
• Oncology
• Thrombosis
• +7 more

Agostino Buono serves as Assistant Professor of Small Animal Internal Medicine in the Department of Veterinary Clinical Sciences at Louisiana State University's School of Veterinary Medicine, joining the faculty in July 2024. A Diplomate of the American College of Veterinary Internal Medicine (SAIM), he bridges clinical practice and translational research in gastrointestinal diseases. His research focuses on gastrointestinal disease pathogenesis , particularly the triad of diet-microbiome-immune system interactions in conditions like chronic inflammatory enteropathy and protein-losing enteropathy. Current investigations include fecal microbiota transplantation safety profiles, dysbiosis metabolomics, and immune biomarker validation for inflammatory conditions. Dr. Buono's scholarly impact is evidenced by publications in the Journal of Veterinary Internal Medicine (7 papers 2019-2024), including a 2024 study on FMT immune effects and 2019 work on soluble CD25 assay development. His research program demonstrates strong translational potential for canine gastrointestinal therapeutics. 2018: Comparative Gastroenterology Society Research Award (ACVIM oral presentation) 2017: Comparative Gastroenterology Society Research Award (ACVIM poster presentation) As a new faculty member, Dr. Buono is establishing his research trajectory with active collaborations across veterinary academia. His clinical expertise in immune-mediated diseases and dyslipidemia informs both student training and innovative therapeutic approaches. Prospective students would engage in clinically relevant projects spanning microbiome analysis, biomarker validation, and therapeutic trials within LSU's veterinary hospital ecosystem.

• Gastrointestinal Diseases
• Veterinary Internal Medicine
• Microbiome Research
• +3 more

Dr. Christine Navarre serves as Adjunct Professor in the Department of Veterinary Clinical Sciences at LSU School of Veterinary Medicine and Professor in LSU School of Animal Sciences, while also functioning as Extension Veterinarian for LSU AgCenter. Her career integrates academic instruction, clinical practice, and extension services focused exclusively on food animal systems, particularly beef cattle health and management. Her educational foundation includes: DVM from LSU School of Veterinary Medicine (1990) MS from Texas A&M University (1994) Dr. Navarre's research centers on applied ruminant parasitology in southern climates, with significant contributions to gastrointestinal nematode control and disaster response for livestock operations. Her clinical expertise drives innovations in beef cattle preventive medicine, while her extension work translates research into practical herd health management strategies. Recent publications address emerging challenges like hurricane-related livestock fatalities and antimicrobial stewardship. Her publication record demonstrates consistent impact across parasitology, disaster medicine, and food animal production, with notable emphasis on practical applications for beef producers. The 2022 study on mosquito-borne livestock mortality after Hurricane Laura exemplifies her focus on climate-related production challenges, while her ongoing work with the Council for Agricultural Science and Technology addresses systemic veterinary workforce issues. Dr. Navarre's exceptional recognition includes: Triple 2023 awards: Food Animal Speaker of the Year, LA Veterinarian of the Year, Beef Quality Assurance Educator American Association of Bovine Practitioners Distinguished Service Award (2019) El Toro Award for Food Animal Medicine Excellence (2010) Norden Distinguished Teaching Award (1997) As an educator, she lectures across veterinary and animal sciences programs on food animal medicine, leveraging her Diplomate status with the American College of Veterinary Internal Medicine. Her leadership extends to presidential roles in major veterinary organizations, where she shapes national discourse on bovine practice and veterinary community development. Though no dedicated research lab is documented, her work through LSU AgCenter creates direct pathways for research translation to producers.

• Ruminant Parasitology
• Beef Cattle Health
• Food Animal Medicine
• +4 more

Dr. Russell Van Dyke is a Clinical Professor and Section Chief of Pediatric Infectious Diseases at Tulane University School of Medicine. His affiliations include primary appointment at Tulane, collaborative roles in the Pediatric HIV/AIDS Cohort Study (PHACS) and International Maternal Adolescent and Pediatric AIDS Clinical Trials Network, with prior training at Medical College of Wisconsin and UC San Diego. His research expertise spans: Antiviral chemotherapy and sensitivity testing Rapid viral diagnostics Immunologic responses to respiratory syncytial virus Development of RSV monoclonal antibodies Perinatal HIV epidemiology, prevention, and treatment Pathogenesis of vertical HIV transmission HTLV-1/II infection epidemiology Long-term outcomes of youth with perinatal HIV Recent publications (2016-2017) predominantly investigate perinatal HIV outcomes through cohort studies, examining neurocognitive impacts, metabolic complications, viral dynamics, and antiretroviral safety. Work frequently involves multi-center collaborations like PHACS. Awards recognizing his research include: CDC Charles C. Shepard Science Award (2005) Tulane Board of Governors Awards for Research Leadership & Distinction (2007) CDC James H. Nakano Citation Award (2016) Dr. Van Dyke leads studies on antiretroviral safety (e.g., PHACS SMARTT) and perinatal HIV outcomes through NIH-funded cohort initiatives, focusing on translational impacts for pediatric HIV care.

• Pediatrics
• Infectious Diseases
• HIV/AIDS
• +5 more

Dr. Wesley Adam Mayer is an Associate Professor of Urology and Vice Chair for Education in the Scott Department of Urology at Baylor College of Medicine, where he also serves as Assistant Dean for Graduate Medical Education. His clinical practice focuses on advanced minimally invasive surgical treatments for complex urologic conditions. BA with Distinction from Cornell University (2001) MD with Highest Honors from Baylor College of Medicine (2005) General Surgery Internship and Urology Residency at University of Pennsylvania (2006-2010) Minimally Invasive Surgery Fellowship at Baylor College of Medicine (2011) Dr. Mayer's research centers on robotic and laparoscopic surgical innovations for kidney cancer, stone disease, and transplant urology. His work on renal mass scoring systems and single-site donor nephrectomy has established new clinical benchmarks. The integration of surgical education methodology with technical innovation represents a unique aspect of his scholarly contributions. His publication record shows consistent output in high-impact urology journals, with recent emphasis on surgical education frameworks and minimally invasive technique optimization. The research demonstrates strong translational impact, with several innovations adopted into national training curricula. Two-time Fulbright Faculty Excellence Award recipient (Educational Leadership 2019, Teaching 2018) Faculty Teacher of the Year (2021) Multiple "Top Doctor" designations (Houstonia Magazine 2019-2021, TX Top Docs 2021) American Urological Association Teaching Award nominee (2020) Alpha Omega Alpha Honor Society inductee As an educator, Dr. Mayer directs multiple residency training initiatives and serves on national committees shaping urologic education. His ACGME Urology Milestones 2.0 work has transformed competency assessment across all US residency programs. He maintains active collaborations with transplant centers and regularly contributes to national educational courses including the AUA Oral Board Examination Review.

• Minimally Invasive Urologic Surgery
• Robotic Surgery
• Endourology
• +8 more

Dr. Andrew J. Goodwin IV, M.D. serves as Professor and Interim Chair of Pathology and Laboratory Medicine at the Larner College of Medicine at the University of Vermont. His leadership roles include Vice Chair of Quality and Clinical Affairs, Division Chief for Laboratory Medicine, Medical Director for the Coagulation Laboratory, and Director for Faculty Recruitment and Retention. As an American Board of Pathology certified pathologist in both Anatomic and Clinical Pathology, Dr. Goodwin maintains clinical responsibilities as Section Medical Director of Thrombosis & Hemostasis at the University of Vermont Medical Center and as a CLIA Laboratory Medical Director across multiple institutions in Vermont, northern New York, and New Hampshire. Dr. Goodwin's research focuses on laboratory thrombosis and hemostasis, with publications spanning quality laboratory testing for thrombotic and hemostatic diseases. His work addresses critical issues in anticoagulant monitoring, D-dimer testing methodologies, von Willebrand factor assays, and point-of-care testing validation. He has also made significant contributions to surgical pathology, particularly in breast and cervical pathology. Recognized nationally for contributions to laboratory quality and accreditation, Dr. Goodwin serves on the Council for Scientific Affairs for the College of American Pathologists. His leadership extends to educational innovation, having created the Laboratory Management Course Curriculum in 2014 to train pathology residents in operational and regulatory aspects of laboratory medicine. As Interim Chair, Dr. Goodwin champions strategic initiatives including digital anatomic pathology with AI integration, laboratory stewardship for genomic medicine testing, and creative funding opportunities to support innovative research and education. His current focus emphasizes advancing patient care through innovation, collaboration, and service while maintaining the department's mission of quality clinical care, effective education, and well-funded research. Dr. Goodwin has received multiple teaching awards for his dedication to medical education and has mentored numerous trainees and faculty throughout his career. His scholarly work appears in prominent journals including the New England Journal of Medicine, Archives of Pathology & Laboratory Medicine, and American Journal of Hematology.

• Thrombosis and Hemostasis
• Laboratory Medicine
• Pathology
• +7 more

Dr. Neli Ragina serves as Associate Professor and Assistant Dean for Undergraduate Medical Education (UME) and Graduate Medical Education (GME) Research at Central Michigan University's College of Medicine. In this leadership role, she oversees all student and resident research activities across clinical sites and the CMU Global Campus, providing strategic direction for clinical, biomedical, and translational investigations while ensuring regulatory compliance. Her academic foundation includes: Ph.D. from Michigan State University M.S. from University of Southern California M.S. from Sofia University Postdoctoral Fellowship at University of Southern California Dr. Ragina's research program bridges molecular biology and population health. Her translational work investigates epigenetic mechanisms underlying disease processes, while her population health research examines behavioral factors and social determinants affecting people with disabilities. Since establishing the student population health research lab in 2016, she has created a training ground for medical trainees to engage in meaningful health disparities research. Her scholarly output demonstrates consistent productivity across diverse domains including cardiology, oncology, emergency medicine, and medical education. Dr. Ragina's scientific contributions have been recognized with multiple awards: Young Researcher's Award Genetic Program Travelling Fellowship Graduate School Travelling Award International Studies Travelling Fellowship REU Graduate Mentor Fellowship First award for oral Presentation As an educator, Dr. Ragina teaches epidemiology, research compliance, reproduction, genetics, and cancer throughout the medical curriculum for students (Years 1-4) and residents. Her mentorship extends beyond the classroom through the student population health research lab, where she guides medical students and residents in developing research projects focused on health disparities. She maintains active collaborations across multiple departments as evidenced by her diverse publication record. Dr. Ragina leads the student population health research lab, which serves as both a research hub and training platform. The lab's work addresses critical gaps in understanding how social determinants impact health outcomes for vulnerable populations, particularly people with disabilities. Through this lab, she cultivates the next generation of physician-scientists equipped to address complex health disparities through both clinical practice and research.

• Epigenetics
• Behavioral Health
• Social Determinants of Health
• +4 more